Concorde Financial’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-322,869
Closed -$1.63M 40
2023
Q4
$1.63M Buy
+322,869
New +$1.58M 1.12% 31
2023
Q3
Sell
-383,607
Closed -$3.66M 32
2023
Q2
$3.66M Buy
383,607
+87,027
+29% +$736K 2.4% 20
2023
Q1
$2.52M Buy
296,580
+98,766
+50% +$1.09M 1.83% 26
2022
Q4
$2.4M Hold
197,814
1.62% 28
2022
Q3
$2.4M Sell
197,814
-4,540
-2% -$68.8K 1.62% 28
2022
Q2
$3.15M Buy
202,354
+45,640
+29% +$821K 3.52% 13
2022
Q1
$2.95M Buy
156,714
+16,681
+12% +$359K 1.81% 27
2021
Q4
$3.31M Buy
+140,033
New +$3M 2.08% 23

Other funds holding MPT

Concorde Financial's MPT Position: Q1 2024 in Review

Concorde Financial sold out of Medical Properties Trust (MPT) in Q1 2024, closing a stake of 322,869 shares — an estimated $1.63M sold.

Concorde Financial first reported a position in MPT in Q4 2021 and held it in 8 quarters. The position peaked at $3.66M in Q2 2023. 510 funds tracked by Wall St. Rank hold MPT as of Q1 2024.

  • Concorde Financial reported no remaining Medical Properties Trust position as of Q1 2024 after selling out during the quarter.
  • Concorde Financial sold 322,869 Medical Properties Trust shares in Q1 2024, an estimated $1.63M.
  • Concorde Financial first reported a position in Medical Properties Trust in Q4 2021 and held it in 8 quarters.
  • Concorde Financial's Medical Properties Trust position peaked at $3.66M in Q2 2023.
  • 510 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2024.

Based on Concorde Financial's 13F filing for Q1 2024, filed 15 May 2024.